Senores Pharmaceuticals is a leading pharmaceutical company driven by a mission to bridge the gap between affordable healthcare and accessibility. We manufacture and market an extensive range of APls, and Finished Dosage Forms and specialize in tablets, capsules, injectables (ampoules, liquid vials, lyophilized injections and dry powder injections), dry powder (oral suspension), and oral liquids in finished dosage forms. We have a state-of-the-art advanced manufacturing plant with automation in the USA with a total area of 50,000 sq. ft. In India, we have a dedicated ultra-modern manufacturing facility of 9,00,000 sq. ft. for Formulations and a hi-tech facility of 2,25,000 sq. ft. for manufacturing high-value and quality APIs for domestic, semi-regulated, and regulated markets. The facilities are approved by USFDA, Middle Eastern countries, SAARC, LATAM, CIS countries, and more than 20 African MOH. We are committed to the highest quality and compliance standards in every activity we undertake. Senores focuses on key therapeutic areas like CNS, Cardiovascular, Anti-Diabetic, Gastrointestinal, Anti-Fungal, Anti-Malarial, Anti-Viral, Anti-Biotic, Gynaecology, Analgesic, and Anaesthetic. With a footprint in more than 50 countries, the group is present in the regulated markets (US & Canada), semi-regulated markets (Turkey & Israel), and less regulated/ emerging markets (CIS, LATAM, Far East & Africa).